San Francisco, CA3 Active Studies

Multiple Sclerosis Clinical Trials in San Francisco, CA

Find 3 actively recruiting multiple sclerosis clinical trials in San Francisco, CA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
334
Enrolling

Recruiting Multiple Sclerosis Studies in San Francisco

About Multiple Sclerosis Clinical Trials in San Francisco

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 3 multiple sclerosis clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 334 participants. Research is being sponsored by Celgene, University of Kansas Medical Center, Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in San Francisco — FAQ

Are there multiple sclerosis clinical trials in San Francisco?

Yes, there are 3 multiple sclerosis clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 3 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated March 2, 2026 from ClinicalTrials.gov